203 related articles for article (PubMed ID: 24762746)
1. New genetic biomarkers predicting azathioprine blood concentrations in combination therapy with 5-aminosalicylic acid.
Uchiyama K; Takagi T; Iwamoto Y; Kondo N; Okayama T; Yoshida N; Kamada K; Katada K; Handa O; Ishikawa T; Yasuda H; Sakagami J; Konishi H; Yagi N; Naito Y; Itoh Y
PLoS One; 2014; 9(4):e95080. PubMed ID: 24762746
[TBL] [Abstract][Full Text] [Related]
2. 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.
Hande S; Wilson-Rich N; Bousvaros A; Zholudev A; Maurer R; Banks P; Makrauer F; Reddy S; Burakoff R; Friedman S
Inflamm Bowel Dis; 2006 Apr; 12(4):251-7. PubMed ID: 16633046
[TBL] [Abstract][Full Text] [Related]
3. The potential influence of 5-aminosalicylic acid on the induction of myelotoxicity during thiopurine therapy in inflammatory bowel disease patients.
Gao X; Zhang FB; Ding L; Liu H; Wang XD; Chen BL; Bi HC; Xiao YL; Zhao LZ; Chen MH; Huang M; Hu PJ
Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):958-64. PubMed ID: 22664938
[TBL] [Abstract][Full Text] [Related]
4. Influence of 5-aminosalicylic acid on 6-thioguanosine phosphate metabolite levels: a prospective study in patients under steady thiopurine therapy.
de Graaf P; de Boer NK; Wong DR; Karner S; Jharap B; Hooymans PM; Veldkamp AI; Mulder CJ; van Bodegraven AA; Schwab M
Br J Pharmacol; 2010 Jul; 160(5):1083-91. PubMed ID: 20590602
[TBL] [Abstract][Full Text] [Related]
5. Thiopurine Methyltransferase Genetic Polymorphisms and Activity and Metabolic Products of Azathioprine in Patients with Inflammatory Bowel Disease.
Pashazadeh P; Marjani A; Asadi J; Khoshnia M
Endocr Metab Immune Disord Drug Targets; 2019; 19(4):541-547. PubMed ID: 30451123
[TBL] [Abstract][Full Text] [Related]
6. Impact of Genetic Polymorphisms on 6-Thioguanine Nucleotide Levels and Toxicity in Pediatric Patients with IBD Treated with Azathioprine.
Lee MN; Kang B; Choi SY; Kim MJ; Woo SY; Kim JW; Choe YH; Lee SY
Inflamm Bowel Dis; 2015 Dec; 21(12):2897-908. PubMed ID: 26332308
[TBL] [Abstract][Full Text] [Related]
7. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
[TBL] [Abstract][Full Text] [Related]
8. Relationship between azathioprine dosage, 6-thioguanine nucleotide levels, and therapeutic response in pediatric patients with IBD treated with azathioprine.
Lee MN; Kang B; Choi SY; Kim MJ; Woo SY; Kim JW; Choe YH; Lee SY
Inflamm Bowel Dis; 2015 May; 21(5):1054-62. PubMed ID: 25851563
[TBL] [Abstract][Full Text] [Related]
9. The impact of thiopurine-S-methyltransferase genotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases.
Hlavaty T; Batovsky M; Balakova D; Pav I; Celec P; Gregus M; Zakuciova M; Hlista M; Horakova M; Desatova B; Koller T; Toth J; Kadasi L; Huorka M;
Bratisl Lek Listy; 2013; 114(4):199-205. PubMed ID: 23514552
[TBL] [Abstract][Full Text] [Related]
10. Prospective Evaluation of Pharmacogenomics and Metabolite Measurements upon Azathioprine Therapy in Inflammatory Bowel Disease: An Observational Study.
Fangbin Z; Xiang G; Liang D; Hui L; Xueding W; Baili C; Huichang B; Yinglian X; Peng C; Lizi Z; Yanjun C; Feng X; Minhu C; Min H; Pinjin H
Medicine (Baltimore); 2016 Apr; 95(15):e3326. PubMed ID: 27082580
[TBL] [Abstract][Full Text] [Related]
11. Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?
Fangbin Z; Xiang G; Minhu C; Liang D; Feng X; Min H; Pinjin H
Ther Drug Monit; 2012 Dec; 34(6):695-701. PubMed ID: 23149442
[TBL] [Abstract][Full Text] [Related]
12. Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease.
Cuffari C; Dassopoulos T; Turnbough L; Thompson RE; Bayless TM
Clin Gastroenterol Hepatol; 2004 May; 2(5):410-7. PubMed ID: 15118980
[TBL] [Abstract][Full Text] [Related]
13. Association between Thiopurine S-Methyltransferase Polymorphisms and Azathioprine-Induced Adverse Drug Reactions in Patients with Autoimmune Diseases: A Meta-Analysis.
Liu YP; Xu HQ; Li M; Yang X; Yu S; Fu WL; Huang Q
PLoS One; 2015; 10(12):e0144234. PubMed ID: 26633017
[TBL] [Abstract][Full Text] [Related]
14. High thiopurine metabolite concentrations associated with lymphopenia in inflammatory bowel disease (IBD) pediatric patients receiving aminosalicylates combined with azathioprine.
Nguyen TM; Le Gall C; Lachaux A; Boulieu R
Int J Clin Pharmacol Ther; 2010 Apr; 48(4):275-81. PubMed ID: 20353749
[TBL] [Abstract][Full Text] [Related]
15. 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease.
Dubinsky MC; Yang H; Hassard PV; Seidman EG; Kam LY; Abreu MT; Targan SR; Vasiliauskas EA
Gastroenterology; 2002 Apr; 122(4):904-15. PubMed ID: 11910342
[TBL] [Abstract][Full Text] [Related]
16. A 6-thioguanine nucleotide threshold level of 400 pmol/8 x 10(8) erythrocytes predicts azathioprine refractoriness in patients with inflammatory bowel disease and normal TPMT activity.
Roblin X; Peyrin-Biroulet L; Phelip JM; Nancey S; Flourie B
Am J Gastroenterol; 2008 Dec; 103(12):3115-22. PubMed ID: 19086961
[TBL] [Abstract][Full Text] [Related]
17. Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: effect of N-acetyl transferase polymorphisms.
Stocco G; Cuzzoni E; De Iudicibus S; Favretto D; Malusà N; Martelossi S; Pozzi E; Lionetti P; Ventura A; Decorti G
World J Gastroenterol; 2015 Mar; 21(12):3571-8. PubMed ID: 25834322
[TBL] [Abstract][Full Text] [Related]
18. Deletion of glutathione-s-transferase m1 reduces azathioprine metabolite concentrations in young patients with inflammatory bowel disease.
Stocco G; Cuzzoni E; De Iudicibus S; Franca R; Favretto D; Malusà N; Londero M; Cont G; Bartoli F; Martelossi S; Ventura A; Decorti G
J Clin Gastroenterol; 2014 Jan; 48(1):43-51. PubMed ID: 23787247
[TBL] [Abstract][Full Text] [Related]
19. TPMT and ITPA genetic variants in Lithuanian inflammatory bowel disease patients: Prevalence and azathioprine-related side effects.
Steponaitiene R; Kupcinskas J; Survilaite S; Varkalaite G; Jonaitis L; Kiudelis G; Denapiene G; Valantinas J; Skieceviciene J; Kupcinskas L
Adv Med Sci; 2016 Mar; 61(1):135-40. PubMed ID: 26674571
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of azathioprine metabolites for the maintenance of remission in autoimmune hepatitis.
Dhaliwal HK; Anderson R; Thornhill EL; Schneider S; McFarlane E; Gleeson D; Lennard L
Hepatology; 2012 Oct; 56(4):1401-8. PubMed ID: 22488741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
